Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02498912
Brief Title: Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

First Submitted : July 10, 2015
First Submitted that Met QC Criteria : July 13, 2015
First Posted : July 15, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 9, 2019
Last Update Posted : April 11, 2019